1-hydroxyaklavinone has been researched along with Leukemia L 1210 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Matsuzawa, Y; Naganawa, H; Oki, T; Takeuchi, T; Umezawa, H; Yoshimoto, A | 1 |
1 other study(ies) available for 1-hydroxyaklavinone and Leukemia L 1210
Article | Year |
---|---|
Microbial conversion of epsilon-pyrromycinone and epsilon-isorhodomycinone to 1-hydroxy-13-dihydrodaunomcyin and N-formyl-1-hydroxy-13-dihydrodaunomycin and their bioactivities.
Topics: Animals; Anthracyclines; Anti-Bacterial Agents; Antibiotics, Antineoplastic; Biotransformation; Chemical Phenomena; Chemistry, Physical; Daunorubicin; Leukemia L1210; Mice; Mutagens; Mutation; Naphthacenes; Streptomyces | 1980 |